Management of Splenic Abscesses

Initial Recommendation

The American College of Physicians recommends starting immediate intravenous broad-spectrum antibiotics targeting Staphylococcus aureus and Streptococcus viridans as soon as a splenic abscess is suspected, then proceeding with image-guided percutaneous drainage for abscesses >4 cm or symptomatic ones, reserving splenectomy for cases of rupture, drainage failure, or multiple complex abscesses 1

Administer intravenous broad-spectrum antibiotics immediately, as S. aureus and Streptococcus viridans each account for approximately 40% of cases with positive cultures, particularly in abscesses associated with endocarditis 1, 2
Obtain an abdominal CT scan with intravenous contrast as the reference examination, which demonstrates a sensitivity and specificity of 90-95% for identifying abscesses as contrast-enhanced cystic lesions 1
Monitor hemodynamic stability with frequent vital signs, serial hematocrit measurements, and look for signs of persistent infection, including ongoing fever, abdominal pain, and bacteremia 1

The European Society of Radiology recommends percutaneous catheter drainage (PCD) under CT or ultrasound guidance as the first-line treatment after antibiotic stabilization, with success rates of 90% for unilocular abscesses >4 cm and 80-90% overall 1
Maintain drainage until the catheter output is <10-20 mL/day, infection signs disappear, and control imaging confirms abscess resolution 1

Proceed directly to splenectomy for multiple or multilocular abscesses, as percutaneous drainage shows high failure rates (14.3-75%) in this context 2

Proceed immediately to splenectomy in the following situations: splenic rupture with hemorrhage and hemodynamic instability 3, 1
Failure of percutaneous drainage with persistent infection 1
Absence of a safe window for percutaneous access 1
Multiple complex or multilocular abscesses 1, 2
High risk of bleeding contraindicating percutaneous intervention 1
Persistent or recurrent bacteremia despite appropriate antibiotics and drainage 1

In patients with infectious endocarditis requiring valve surgery, perform splenectomy before valve replacement to prevent prosthetic valve infection from splenic bacteremia 3, 2

After any splenectomy, immediately institute a protocol for preventing post-splenectomy sepsis (PSS): administer pneumococcal, meningococcal, and Haemophilus influenzae type B vaccines, ideally ≥14 days after splenectomy 4, 1, 2
Prescribe lifelong antibioprophylaxis: amoxicillin 3 g initial dose then 1 g every 8 hours for acute febrile episodes 4
For patients allergic to beta-lactams: levofloxacin 500 mg/24h or moxifloxacin 400 mg/24h 4
Revaccinate every 5-10 years 1
Vaccinate annually against influenza for patients >6 months, as influenza prevention reduces the risk of secondary bacterial infection 4

Never rely solely on antibiotics for large abscesses (>4 cm), as this approach has high failure rates and untreated sepsis mortality 1
Do not aspirate a suspected hematoma after drainage, as this risks introducing infection into a sterile blood collection and may worsen bleeding 5
Persistent or recurrent fever, abdominal pain, or bacteremia days after aspiration should trigger immediate re-imaging 5
Maintain increased vigilance for hematogenous seeding and persistent infection in intravenous drug users 1
Provide patient education on the risk of PSS, the need for immediate medical attention in case of fever, and consider a Medic-Alert identification 1

Start intravenous ceftazidime or a carbapenem (meropenem or imipenem), with or without trimethoprim‑sulfamethoxazole, for 10–14 days (or longer if clinically indicated) in patients with splenic abscesses caused by Burkholderia pseudomallei. 6
Meropenem and imipenem show universal in‑vitro susceptibility against B. pseudomallei isolates and are the preferred agents for severe melioidosis. 7
Ceftazidime provides comparable clinical efficacy to carbapenems and remains a widely used first‑line option. 6
Avoid ertapenem, azithromycin, moxifloxacin, and amoxicillin‑clavulanate because B. pseudomallei is resistant to these drugs. 7
In patients presenting with septic shock, add granulocyte‑colony stimulating factor (G‑CSF) to meropenem therapy, following protocols from high‑volume centers. 6

After the intensive phase, switch to oral trimethoprim‑sulfamethoxazole for 12–20 weeks (with or without doxycycline) to prevent disease relapse. 6
Amoxicillin‑clavulanate has markedly lower efficacy and should be reserved only for pregnant women, children, or patients intolerant to first‑line agents. 6

Do not discontinue antimicrobial therapy before completing a total of 12–20 weeks (intravenous + oral); premature cessation is associated with relapse. 6